Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessBevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
A total of 50 patients with advanced pancreatic cancer were enrolled in a phase II study of bevacizumab 15 mg kg−1, capecitabine 1300 mg m−2 daily for 2 weeks and gemcitabine 1000 mg m−2 weekly 2 times; cycles we...
-
Article
Radical reresection is indicated for all T2 and T3 gallbladder cancers and results in the same survival as primarily resected gallbladder cancers
-
Article
Radical reresction in indicated for all T2 and T3 gallbladder and results in the same survival as primarily resected gallbladder cancers H Hoshi, JM Foster, Q Chu, B Kuvshinoff, A Rajput, H Nava, JF Gibbs Department of Surgery, Roswell Park Cancer Institute, State University of New York at Buffalo, Elm & Carlton Streets, Buffalo, NY